JPWO2023008511A1 - - Google Patents
Info
- Publication number
- JPWO2023008511A1 JPWO2023008511A1 JP2023538613A JP2023538613A JPWO2023008511A1 JP WO2023008511 A1 JPWO2023008511 A1 JP WO2023008511A1 JP 2023538613 A JP2023538613 A JP 2023538613A JP 2023538613 A JP2023538613 A JP 2023538613A JP WO2023008511 A1 JPWO2023008511 A1 JP WO2023008511A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227035P | 2021-07-29 | 2021-07-29 | |
| PCT/JP2022/029062 WO2023008511A1 (ja) | 2021-07-29 | 2022-07-28 | Ｂａｐ１およびｐｂｒｍ１の少なくとも１つの機能低下を有する腫瘍に対する医薬組成物および抗腫瘍剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023008511A1 true JPWO2023008511A1 (https=) | 2023-02-02 |
Family
ID=85087010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538613A Pending JPWO2023008511A1 (https=) | 2021-07-29 | 2022-07-28 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240207301A1 (https=) |
| EP (1) | EP4378466A4 (https=) |
| JP (1) | JPWO2023008511A1 (https=) |
| KR (1) | KR20240028451A (https=) |
| CN (1) | CN117794548A (https=) |
| WO (1) | WO2023008511A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997038001A1 (en) | 1996-04-09 | 1997-10-16 | Yamasa Corporation | 1-(2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINES |
| RU2559364C2 (ru) | 2009-12-18 | 2015-08-10 | Либрамедисина, Инк. | СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ 1-О-АЦИЛ-2-ДЕЗОКСИ-2-ФТОР-4-ТИО-β-D-АРАБИНОФУРАНОЗ |
| SG10201603288XA (en) | 2012-03-28 | 2016-05-30 | Fujifilm Corp | Salt Of 1-(2-Deoxy-2-Fluoro-4-Thio-beta-D-Arabinofuranosyl)Cytosine |
| KR20170001722A (ko) | 2012-08-13 | 2017-01-04 | 후지필름 가부시키가이샤 | 1-(2-데옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 합성 중간체, 티오뉴클레오시드의 합성 중간체, 및 그들의 제조법 |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| JP6450356B2 (ja) | 2016-02-29 | 2019-01-09 | 富士フイルム株式会社 | 液状医薬製剤 |
| IL265044B2 (en) | 2016-08-31 | 2025-02-01 | Fujifilm Corp | An antitumor preparation containing the substances nab-paclitaxel and 1-(2-deoxy-2-fluoro-4-thio-D-beta-arabinofurnosyl)cytosine, a kit containing these substances and their uses |
| WO2019146130A1 (ja) | 2018-01-29 | 2019-08-01 | 富士フイルム株式会社 | 胆道がん用抗腫瘍剤および胆道がんの処置方法 |
| TW201932120A (zh) | 2018-01-29 | 2019-08-16 | 日商富士軟片股份有限公司 | 用於具有異檸檬酸脫氫酶突變的腫瘤的藥物組成物與抗腫瘤劑及其應用 |
| WO2019164010A1 (ja) | 2018-02-26 | 2019-08-29 | 富士フイルム株式会社 | 膀胱がん用抗腫瘍剤および膀胱がんの処置方法 |
| WO2019176984A1 (ja) | 2018-03-13 | 2019-09-19 | 富士フイルム株式会社 | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット |
| WO2019176985A1 (ja) | 2018-03-13 | 2019-09-19 | 富士フイルム株式会社 | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット |
-
2022
- 2022-07-28 JP JP2023538613A patent/JPWO2023008511A1/ja active Pending
- 2022-07-28 EP EP22849572.7A patent/EP4378466A4/en active Pending
- 2022-07-28 KR KR1020247003085A patent/KR20240028451A/ko active Pending
- 2022-07-28 CN CN202280052941.2A patent/CN117794548A/zh active Pending
- 2022-07-28 WO PCT/JP2022/029062 patent/WO2023008511A1/ja not_active Ceased
-
2024
- 2024-01-26 US US18/424,360 patent/US20240207301A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4378466A4 (en) | 2024-11-20 |
| EP4378466A1 (en) | 2024-06-05 |
| CN117794548A (zh) | 2024-03-29 |
| US20240207301A1 (en) | 2024-06-27 |
| WO2023008511A1 (ja) | 2023-02-02 |
| KR20240028451A (ko) | 2024-03-05 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250407 |